Back to search

Article

Global variation in the SARS-CoV-2 proteome reveals the mutational hotspots in the drug and vaccine candidates

2020-07-31

Abstract excerpt

<h4>ABSTRACT</h4> To accelerate the drug and vaccine development against the severe acute respiratory syndrome virus 2 (SARS-CoV-2), a comparative analysis of SARS-CoV-2 proteome has been performed in two phases by considering manually curated 31389 whole genome sequences from 84 countries. Among the 9 mutations that occur at a high significance (T85I-NPS2, L37F-NSP6, P323L-NSP12, D614G-spike, Q57H-ORF3a, G251V-O...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8c72834-34d6-5267-8169-3519531bf904
DOI
10.1101/2020.07.31.230987
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Global variation in the SARS-CoV-2 proteome reveals the mutational hotspots in the drug and vaccine candidatesDOI 10.1101/2020.07.31.230987
Select a neighboring publication to make it the new centre.